"4" . "Actinic keratoses are a sun induced cutaneous lesion, currently considered as a squamous cell carcinoma in situ that has the potential to progress to invasive SCC. To treat them, numerous, ablative and no ablative, therapeutic approaches exist. Among them, imiquimod, a toll like receptor agonist, is effective and safe with an acceptable tolerability in the treatment of AK."@en . "3"^^ . "Vantuchov\u00E1, Yvetta" . . . "P\u0159\u00EDsp\u011Bvek k l\u00E9\u010Db\u011B aktinick\u00FDch kerat\u00F3z" . . . "RIV/00843989:_____/09:00100528" . . "P\u0159\u00EDsp\u011Bvek k l\u00E9\u010Db\u011B aktinick\u00FDch kerat\u00F3z" . "P\u0159\u00EDsp\u011Bvek k l\u00E9\u010Db\u011B aktinick\u00FDch kerat\u00F3z"@cs . "Paciorek, Martin" . . . "Aktinick\u00E9 kerat\u00F3zy (AK) vznikaj\u00ED \u00FA\u010Dinkem slune\u010Dn\u00EDho z\u00E1\u0159en\u00ED a jsou dnes pova\u017Eov\u00E1ny za spinocelul\u00E1rn\u00ED karcinom (SCC) in situ, kter\u00FD m\u00E1 schopnost r\u016Fstu v invazivn\u00ED SCC. K l\u00E9\u010Db\u011B AK je dostupn\u00E9 mno\u017Estv\u00ED ablativn\u00EDch a neablativn\u00EDch modalit, mezi kter\u00FDmi je imiquimod, agonista na toll like receptorech, pova\u017Eov\u00E1n za bezpe\u010Dn\u00FD a \u00FA\u010Dinn\u00FD p\u0159\u00EDpravek k l\u00E9\u010Db\u011B AK s dobrou sn\u00E1\u0161enlivost\u00ED." . . "RIV/00843989:_____/09:00100528!RIV10-MZ0-00843989" . . . "3" . "Treatment of actinic keratoses"@en . "Dermatologie pro praxi" . . "336294" . "actinic keratosis; imiquimod"@en . . . "[F99F0A3D499E]" . "Treatment of actinic keratoses"@en . "P\u0159\u00EDsp\u011Bvek k l\u00E9\u010Db\u011B aktinick\u00FDch kerat\u00F3z"@cs . "3"^^ . . . "CZ - \u010Cesk\u00E1 republika" . "Aktinick\u00E9 kerat\u00F3zy (AK) vznikaj\u00ED \u00FA\u010Dinkem slune\u010Dn\u00EDho z\u00E1\u0159en\u00ED a jsou dnes pova\u017Eov\u00E1ny za spinocelul\u00E1rn\u00ED karcinom (SCC) in situ, kter\u00FD m\u00E1 schopnost r\u016Fstu v invazivn\u00ED SCC. K l\u00E9\u010Db\u011B AK je dostupn\u00E9 mno\u017Estv\u00ED ablativn\u00EDch a neablativn\u00EDch modalit, mezi kter\u00FDmi je imiquimod, agonista na toll like receptorech, pova\u017Eov\u00E1n za bezpe\u010Dn\u00FD a \u00FA\u010Dinn\u00FD p\u0159\u00EDpravek k l\u00E9\u010Db\u011B AK s dobrou sn\u00E1\u0161enlivost\u00ED."@cs . "3"^^ . "Litvik, Radek" . "V" . "1802-2960" .